A comprehensive view of Combination Therapy. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Citius Pharmaceuticals partnering with University of Pittsburg, University of Minnesota in I/ONTAK clinical studies; I/ONTAK is recombinant fusion protein that combines interleukin-2 receptor binding domain with diphtheria toxin fragments

Merck to start new clinical trial to study lower dose of its experimental drug islatravir in combination with Pifeltro doravirine to treat HIV-1; Merck to end development of islatravir as HIV prevention drug

FDA starts priority review of Seagen’s oral metastatic colorectal cancer drug tucatinib; Tukysa to be used in combination with Roche’s Herceptin trastuzumab in adult patients who have had at least one prior treatment regimen

Merck partners with immuno-oncology company Medicenna Therapeutics to test combo therapy in Phase I/II study of solid tumors; therapy includes Medicenna’s MDNA11 as a monotherapy and in combination with Merck’s immunotherapy Keytruda pembrolizumab

Biopharma firm Springworks Therapeutics expands agreement with GSK worth up to US$625.0M to develop blood cancer therapy; therapy to combine Springwork’s nirogacestat and GSK’s drug Blenrep belantamab mafodotin-blmf to treat relapsed multiple myeloma

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count